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Robert H. Christenson, PHD,* Mercedes R. Carnethon, PHD,‡ David S. Siscovick, MD, MPH,§
John S. Gottdiener, MD,* Stephen L. Seliger, MD, MS*
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Objectives The aim of this study was to evaluate the association between physical activity and changes in levels of highly
sensitive troponin T (cTnT) and N-terminal pro–B-type natriuretic peptide (NT-proBNP), and the subsequent risk of
the development of heart failure (HF) in community-dwelling older adults.
Background Higher baseline levels of cTnT and NT-proBNP and increases over time correlate with the risk of HF in older
adults. Factors modifying these levels have not been identified.
Methods NT-proBNP and cTnT were measured at baseline and 2 to 3 years later in adults 65 years of age and older free
of HF participating in the Cardiovascular Health Study. Self-reported physical activity and walking pace were
combined into a composite score. An increase was prespecified for NT-proBNP as a 25% increment from baseline
to 190 pg/ml and for cTnT as a 50% increment from baseline in participants with detectable levels (3 pg/ml).
Results A total of 2,933 participants free of HF had NT-proBNP and cTnT measured at both time points. The probability
of an increase in biomarker concentrations between baseline and follow-up visits was inversely related to the
physical activity score. Compared with participants with the lowest score, those with the highest score had an
odds ratio of 0.50 (95% confidence interval: 0.33 to 0.77) for an increase in NT-proBNP and an odds ratio of
0.30 (95% confidence interval: 0.16 to 0.55) for an increase in cTnT, after adjusting for comorbidities and base-
line levels. A higher activity score associated with a lower long-term incidence of HF. Moreover, at each level of
activity, an increase in either biomarker still identified those at higher risk.
Conclusions These findings suggest that moderate physical activity has protective effects on early heart failure phenotypes,
preventing cardiac injury and neurohormonal activation. (J Am Coll Cardiol 2012;60:2539–47) © 2012 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.08.1006a
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hWith the introduction of highly sensitive (hs) assays for
cardiac troponin T (cTnT), small amounts of cardiac injury
can be detected in the majority of older adults (1,2). Very
low concentrations of cTnT, detectable with the hs assay,
demonstrate graded associations with risk of heart failure
(HF). Furthermore, an increase or decrease in concentration
50% over 2 to 3 years is common among older adults and
predicts a subsequent change in the risk of HF (1). Simi-
larly, both baseline concentrations and change in levels of
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are associated with new-onset HR in community-dwelling
adults (3,4).
See page 2548
The finding that substantial changes in cTnT and NT-
proBNP occur frequently and correlate with changes in a
subsequent risk of HF suggests that the high-risk pheno-
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markers (cardiac injury and neu-
rohormonal activation) may be
modifiable. However, the factors
that determine changes in these
biomarkers are uncertain. Specif-
ically, little is known about the
influence of lifestyle factors on
the trajectory of these biomarker
concentrations, particularly in
older adults who may have had
decades of exposure to traditional
cardiovascular risk factors. The influence of moderate phys-
ical activity is of particular interest because change in activity
evel is associated with a relatively rapid change in the risk
f cardiovascular events, including HF (5–7). However, the
ffect of a modifiable preventive strategy, such as physical
ctivity, on the levels of cardiac-specific biomarkers has
ever been assessed.
We hypothesized that in an ambulatory cohort of older
dults (65 years of age and older) free of HF, cTnT, and
T-proBNP would be less likely to increase and more likely
o decrease at follow-up in individuals with a greater
uration and intensity of habitual leisure-time physical
ctivity.
ethods
tudy population. The CHS (Cardiovascular Heart Study) is
multicenter, prospective, observational cohort study of
ardiovascular disease in older adults. The present analyses
nclude all individuals without a diagnosis of prevalent HF
t study entry or incident HF between the first and second
Abbreviations
and Acronyms
CI  confidence interval
cTnT  cardiac troponin T
HF  heart failure
hs  highly sensitive
NT-proBNP  N-terminal
pro–B-type natriuretic
peptide
OR  odds ratio
Figure 1 Study Participants Included in the Analysis of Physica
(A) Flow of study participants included in the N-terminal pro–B-type natriuretic pep
(B) Flow of study participants included in the cardiac troponin T (TnT) analysis. HFbiomarker measurement, with availability of cTnT and
NT-proBNP serum samples at both baseline (1989 to 1990
for the main cohort and 1992 to 1993 for the African-
American cohort) and follow-up time points (2 and 3 years
later for the main and African-American cohorts, respec-
tively), and complete data on baseline physical activity (see
“Measures of Physical Activity” section). Of the 5,888 CHS
participants, 2,933 individuals were included in this current
analysis for NT-proBNP and 1,757 for cTnT (a measurable
baseline level [i.e., 3 pg/ml] was required for inclusion in
the cTnT analysis) (Fig. 1). Details of data collection and
definition of comorbidities were published previously (1).
ifferences between those with and without available sera
or biomarker measurements were previously reported (1,3).
he CHS was approved by the institutional review boards
f the University of Washington, Seattle, and the partici-
ating centers. All participants gave written informed con-
ent to participate at the time of study enrollment. Our
nalysis was approved by the institutional review board of
he University of Maryland–Baltimore.
iomarker measures. cTnT and NT-proBNP were mea-
ured from serum collections at baseline and first follow-up
ime points (defined previously) in the main and supple-
ental CHS cohorts. All measurements were performed on
erum samples stored at 70°C to 80°C and thawed just
efore testing by individuals blinded to participant data.
T-proBNP and cTnT were measured on the Elecsys 2010
nalyzer (Roche Diagnostics, Indianapolis, Indiana), as
reviously reported (1). The analytical measurement range
or the hs cTnT assay is 3 to 10,000 pg/ml with a 99th
ercentile of a healthy reference population defined at
3.5 pg/ml and a 10% coefficient of variation less than the
ivity and Change in Biomarkers
T-proBNP) analysis.
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NT-proBNP assay was 2% to 5% during the testing period,
and the analytical measurement range for NT-proBNP was
5 to 35,000 pg/ml.
Measures of physical activity. Leisure-time activity was a
self-reported measure of weekly energy expenditure in
kilocalories quantified by participant responses to a modified
Minnesota Leisure-Time Activity Questionnaire that eval-
uated frequency and duration of 15 different activities
during the previous 2 weeks (9). Average walking pace, a
self-reported measure, was classified in ordinal categories
(2, 2 to 3, and 3 mph). Activity and walking pace
information were collected at the time of the baseline
biomarker measures. Using a composite scoring system
previously developed in CHS to predict new-onset diabetes
and validated to predict the risk of decline in renal function,
we summed leisure time activity quartiles (range, 1 to 4) and
walking pace (range, 1 to 3) to generate a combined physical
activity score with a possible range of 2 to 7. To test for
trends, we further categorized individuals with a score of 2
as low activity, those with a score of 3 to 6 as moderate
activity, and those with a score of 7 as high activity (10,11).
Other covariates. Comorbidities, demographic data, and
risk factors were measured at the baseline CHS visit as
previously described (1). CHD was defined as a history of
angina, coronary revascularization, or myocardial infarction.
General health status was self-reported on a Likert scale of
1 to 5; for the present analysis, health status was categorized
as fair or poor versus good, very good, or excellent.
Main outcomes. Main outcomes were a significant in-
crease in cTnT or NT-proBNP and incident HF. A
significant increase in the biomarkers was prespecified on
the basis of previous studies from this cohort (1,3). The cut
points used have been shown to strongly predict the risk of
incident HF and cardiovascular death independently of
baseline concentrations and cardiovascular risk factors (1,3).
A significant increase in cTnT was defined as a 50%
increase in cTnT level between measures among individuals
with detectable (3 pg/ml) baseline levels (1). The rationale
for excluding individuals with undetectable cTnT concen-
trations is that their relative change from baseline cannot be
quantified. A sensitivity analysis was performed including
those with undetectable baseline cTnT, imputing a baseline
concentration of 2.99 pg/ml. A significant increase in
NT-proBNP was defined as a 25% increase to a level
190 pg/ml (3). Incident HF was defined as the first adjudi-
cated HF event occurring after the second biomarker measure-
ment over the course of follow-up. The CHS Events Com-
mittee adjudicated incident HF by reviewing all pertinent data,
including history, physical examination, chest radiography
report, and medication use (12). NT-proBNP and cTnT data
were not available to the adjudicators.
Statistical analysis. Baseline participant characteristics
ere compared across categories of the composite physical
ctivity score using 1-way analysis of variance for Gaussian
ontinuous measures, Cuzik’s nonparametric trend test for (non-Gaussian continuous variable (13), or the score test for
trend in proportions (14). The associations between baseline
physical activity and the odds of a significant increase in
NT-proBNP or cTnT were estimated using separate binary
logistic regression models. Two sets of adjustment covari-
ates were selected a priori on the basis of factors that might
plausibly confound the relationship of activity with bio-
marker change: 1) demographic variables (age, sex, race
[African American vs. other]), and education (more than a
high school education vs. other); and 2) cardiovascular risk
factors and comorbidity (diabetes, hypertension, and coro-
nary heart disease [all characterized as absent, prevalent at
baseline, or incident between the baseline and follow-up
biomarker measurements], body mass index, stroke, emphy-
sema, claudication, and self-reported health status). Because
baseline NT-proBNP and cTnT could plausibly relate to
physical activity level, all logistic regression models were
additionally adjusted for these concentrations.
Incident rates of HF after the second biomarker mea-
surement were estimated with the Kaplan-Meier method
among subgroups defined by baseline physical activity and
change in biomarker, and the difference in incidence rates
was tested using unadjusted Cox proportional hazards
models. Statistical analyses were performed using Stata
version 11 (StataCorp, College Station, Texas).
Results
Among the participants included in this analysis, the me-
dian weekly energy expenditure for leisure activity was 735
(interquartile range, 210 to 1,698) kcal with 768 (26.2%)
reporting a walking pace of 2 mph, 1,251 (42.7%)
between 2 and 3 mph, and 914 (31.2%) 3 mph. Kilocal-
ories expended per week and walking pace were modestly
correlated (  0.23). The baseline characteristics of the
tudy participants on the basis of the 3 categories of physical
ctivity are shown in Table 1. Higher physical activity score
as associated with younger age, male sex, a lower body
ass index, a lower prevalence of coronary heart disease and
raditional cardiovascular risk factors, and better self-
eported health status. Furthermore, greater activity was
ssociated with lower baseline NT-proBNP, cTnT, and
-reactive protein levels.
hysical activity and increases in biomarker concentration.
he probability of a significant increase in NT-proBNP
oncentration between baseline and follow-up visits de-
reased progressively across categories of greater baseline
ctivity score, from 37.4% (95% confidence interval [CI]:
2.0% to 43.1%) in the lowest activity category to 19.5%
95% CI: 15.1% to 24.5%) in the highest activity category
p  0.001) (Fig. 2A). Similarly, the likelihood of a
ignificant increase in cTnT ranged from 30.2% (95% CI:
4.1% to 37.0%) for the low-activity group to 11.4% (95%
I: 7.0% to 17.2%) for the high-activity group (p  0.001)Fig. 2B).
stimate
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did not significantly affect the associations of baseline
physical activity with either NT-proBNP (Table 2) or cTnT
(Table 3). In fully adjusted models, the odds ratio (OR) of
a significant increase in cardiac biomarkers between visits,
comparing the lowest with the highest baseline activity score
category, was 0.50 (95% CI: 0.33 to 0.76) for NT-proBNP
and 0.30 (95% CI: 0.16 to 0.55) for cTnT. To determine
whether associations with significant increases in biomarker
levels were similar for both components of the activity score,
Characteristics of Study Participants by Baseline Composite PhysiTable 1 Characteristics of Study Participants by Baseline Com
Low Activity
(n  310, 10.
Composite Activity Score 2
Leisure time activity, kcal/week 0 (0–52.5)
Age, yrs 73.4 5.5
% male 24.8
% African American 19.0
Baseline body mass index, kg/m2 28.1 5.9
Change in body mass index, kg/m2 0.01 1.9
Baseline SBP, mm Hg 139.5 21.
Change in SBP from baseline to follow-up, mm Hg 1 (9 to 5
Baseline DBP, mm Hg 70.7 11.
Change in DBP from baseline to follow-up, mm Hg 1 (9 to 5
Baseline heart rate, beats/min 69.3 11.
Change in heart rate from baseline to follow-up, beats/min 0.3 11.
eGFR, ml/min/1.73 m2 77.6 24.
Coronary heart disease
Prevalent at baseline 72 (23.2%)
Prevalent at follow-up 81 (26.1%)
Diabetes
Prevalent at baseline 70 (25.5%)
Prevalent at follow-up 63 (20.3%)
Hypertension
Prevalent at baseline 203 (65.5%
Prevalent at follow-up 192 (62.1%
Previous stroke 17 (5.5%)
Major ECG abnormality 87 (29.0%)
Poor or fair self-reported health 108 (34.5%
Beta-blocker use
Baseline 48 (15.5%)
Follow-up 41 (13.2%)
NT-proBNP, median, pg/ml
Baseline 112.9 (57.4–21
Follow-up 180.3 (85.3–37
cTnT, pg/ml
Baseline* 8.9 (5.4–14.
Below detection (3 pg/ml) 94 (31.1%)
Follow-up* 10.6 (5.7–18
C-reactive protein, mg/dl 3.1 (1.8–6.3
Walking distance, blocks/week 4 (0–10)
Alcohol use, 5 drinks/week 24 (7.7%)
Never smoked 143 (46.1%
Values are median (interquartile range), %, mean  SD, or n (%). *Among those with detectable
cTnT cardiac troponin T; DBP diastolic blood pressure; ECG electrocardiographic; eGFR e
blood pressure.we separately tested quartiles of weekly physical activity and the3 categories of walking pace. The unadjusted and adjusted
ORs of a significant increase in NT-proBNP and cTnT across
these categories of activity are shown in Online Tables 1
and 2, respectively. Progressively higher quartiles of
leisure kilocalories per week and faster walking pace were
both significantly associated with a lower adjusted OR for
increase in each biomarker. There were no significant
multiplicative interactions between quartiles of weekly
leisure-time activity and usual walking pace with an
increase in cTnT (p  0.5 for test of interaction) or
ctivity Scoree Physical Activity Score
Composite Activity Score
Test for Trend
(p Value)
Moderate Activity
(n  2,331, 79.5%)
High Activity
(n292, 10%)
3–6 7
735 (310–1,462) 2,240 (3,011–4,256) 0.001
71.9 5.0 70.8 4.0 0.001
38.3 52.7 0.001
15.4 9.6 0.001
26.7 4.4 25.3 3.6 0.001
0.08 1.48 0.18 1.18 0.12
135.3 21.0 134.5 20.5 0.003
1 (6 to 7) 0 (6 to 7) 0.1
70.7 10.9 71.7 10.6 0.30
1 (6 to 7) 0 (6 to 7) 0.07
67.4 10.8 65.2 10.5 .001
0.2 10.4 0.2 11.0 0.9
79.6 22.4 80.3 20.3 0.13
351 (15.1%) 47 (16.1%) 0.006
437 (18.8%) 55 (18.8%) 0.0008
359 (15.4%) 33 (11.3%) 0.001
353 (15.1%) 37 (12.7%) 0.009
0.001
1,333 (57.2%) 150 (51.7%) 0.01
1,333 (57.2%) 151 (51.9%) 0.01
60 (2.6%) 8 (2.7%) 0.04
579 (25.7%) 57 (20.1%) 0.01
403 (17.3%) 22 (7.5%) 0.001
306 (13.1%) 32 (11.0%) 0.1
303 (13.0%) 28 (9.6%) 0.18
110.4 (53.1–190.0) 86.1 (41.5–149.4) 0.001
135.1 (70.0–264.7) 109.3 (61.3–216.3) 0.001
7.5 (5.2–11.1) 7.1 (4.6–10.4) 0.001
897 (39.3%) 118 (41.1%) 0.001
8.0 (4.3–13.6) 6.4 (3.2–11.1) 0.001
2.3 (1.2–4.0) 1.7 (0.9–3.3) 0.001
18 (6–48) 60 (18–126) 0.001
320 (13.8%) 57 (19.7%) 0.001
1,126 (48.4%) 124 (42.5%) 0.4
e cTnT.
d glomerular filtration rate; NT-proBNPN-terminal pro–B-type natriuretic peptide; SBP systoliccal Aposit
,
6%)
8
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5
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increased likelihood of a 50% decrease in cTnT. The
requency of 50% decrease was 16.2% among those
ith a high activity score and 8.2% among those with a
ow activity score (p  0.15). This difference was not
tatistically significant after multivariable adjustment
OR: 1.48; 95% CI: 0.72 to 3.03).
Several sensitivity analyses were performed. First, when
hose participants with initially undetectable cTnT concen-
rations were included (imputing a value of 2.99 pg/ml),
esults were not materially changed (test for trend across
ctivity score, p  0.004). The association of physical
ctivity with a risk of longitudinal increase in cTnT did not
iffer by baseline concentration of cTnT (test for interac-
ion, p  0.7). Second, when participants with any signif-
cant comorbidity (diabetes, coronary heart disease, stroke,
laudication, emphysema, or obesity [body mass index 30
Figure 2
Proportion of Participants
With a Significant Increase in Biomarkers by
Baseline Composite Physical Activity Score
N-terminal pro–B-type natriuretic peptide (NT-proBNP) (A)
or cardiac troponin T (cTnT) (B).kg/m2]) were excluded, associations of increasing baseline nphysical activity with a reduced probability of increasing
biomarker levels were similar to the overall study population
(Online Tables 3a and 3b). Third, when we included only
participants who self-reported their health as good, very
good, or excellent, the adjusted odds of a significant bio-
marker increase diminished across activity levels in a similar
trend as in the entire study population (Online Tables 4a
and 4b). Fourth, among all subjects, additional adjustment
for serum creatinine did not change the associations of the
composite activity score with a change in either biomarker
(data not shown). Fifth, NT-proBNP levels were evaluated
only in the cohort of subjects with baseline detectable cTnT
levels (n  1,757). Results were nearly identical to the
esults for the full NT-proBNP cohort (data not shown).
ast, in the main CHS cohort (excluding the supplemental
frican-American cohort), a second assessment of physical
ctivity and walking pace were available at the time of the
ollow-up biomarker measures. After adjusting for
ollow-up physical activity and walking pace, the results are
ot materially different from the primary analyses, and there
emain highly significant associations of greater activity with
ower risk of increasing biomarker levels (Online Table 5).
ssociation of physical activity score and longitudinal
ncrease in cardiac-specific biomarkers with risk of new-
nset HF. A total of 822 cases of incident HF occurred
ver a median follow-up after the second biomarker mea-
urement of 10.8 years (range, 0.02 to 16.1 years). The
ncidence of HF diminished with progressively higher levels
f fitness in both subjects with and without an increase in
ither biomarker level (Figs. 3A and 3B). To examine the
oint effects of physical activity and longitudinal change in
he cardiac-specific biomarkers on the risk of new-onset
F, we estimated HF incidence rate across 3 categories of
hysical activity representing low, moderate, or high. In
ach category of activity, we evaluated the incidence of
ew-onset HF on the basis of the presence or absence of a
ignificant increase in NT-proBNP and cTnT. In each
ategory of activity, individuals with an increase in NT-
roBNP (Fig. 3A) or cTnT (Fig. 3B) level had a greater
ncidence rate of HF compared with those without an
ncrease in level, with the exception of those in the
ighest activity category and an increase in cTnT. There
as no significant interaction between the baseline activ-
ty group and an increase in NT-proBNP (p  0.8) or
TnT (p  0.6). To evaluate for the competing risk of
ardiovascular death, we repeated the analysis shown in
igures 3A and 3B for the incidence of the combined
ndpoint of new-onset HF or cardiovascular death. The
verall findings are similar for HF incidence alone, and
he results are shown in Online Figures 1a and 1b for
T-proBNP and cTnT, respectively. When survival
nalyses were performed, accounting for the competing
isk of all-cause mortality, associations of exercise with
F were similar to the standard survival analysis (data
ot shown).
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The findings of this study demonstrate a strong inverse
association between progressively higher levels of physical
activity in ambulatory older adults and a lower probability
of a longitudinal increase in cTnT (measured by an hs assay)
and NT-proBNP. Our findings also show that the inci-
dence of new-onset HF is inversely associated with the
extent of self-reported physical activity. Importantly, a
significant increase in biomarkers remained associated with
an increased incidence of HF at any level of physical activity.
The association of greater self-reported physical activity
with a lower probability of an increase in cardiac biomarkers
of injury and hemodynamic stress also remained present
when analyzing only subjects free of significant comorbidity
or those participants who perceived their health to be good,
very good, or excellent. These findings provide support for
the hypothesis that regular moderate physical activity can
mitigate or delay progressive pathophysiological processes
that ultimately result in symptomatic HF.
A consistent finding across multiple community-based
populations is that more physically active individuals are at
lower risk of multiple adverse cardiovascular endpoints
including new-onset HF (15–20). A recent meta-analysis
Association of Composite Physical Activity ScorIncreases in NT-proBNP* Among All Patients WTable 2 Ass ciation of C mposite PhysicalIncreases in NT-proBNP* Among Al
Unadjusted
(n  2,933)
D
Composite Activity Score
2 (n  310, 10.6%) Reference
3 (n  461, 15.7%) 0.74 (0.54–1.02)
4 (n  600, 20.5%) 0.52 (0.38–0.71)
5 (n  688, 23.5%) 0.52 (0.38–0.70)
6 (n  582, 19.8%) 0.58 (0.42–0.78)
7 (n  292, 10.0%) 0.48 (0.33–0.71)
Test for trend p  0.001
Values are odds ratio (95% confidence interval). *Increase from baseli
adjusted for baseline NT-proBNP. †Demographic variables: age, sex, ra
coronary heart disease, claudication, emphysema, stroke, major elec
NT-proBNP  N-terminal pro–B-type natriuretic peptide.
Association of Composite Physical Activity ScorIncrease* in cTnT Among T o e With De ectablTable 3 Ass ciati of C mposite Physic lIncrease* in cTnT Among Those Wi
Unadjusted
(n  1,757)
D
Composite Activity Score
2 (n  208, 11.8%) Reference
3 (n  283, 16.1%) 0.70 (0.37–1.05)
4 (n  363, 20.7%) 0.66 (0.45–0.97)
5 (n  363, 23.1%) 0.66 (0.45–0.96)
6 (n  405, 23.1%) 0.48 (0.32–0.72)
7 (n  167, 9.5%) 0.27 (0.15–0.47)
Test for trend p  0.001
Values are odds ratio (95% confidence interval). *Increase50% from
50% change. All models additionally adjusted for baseline cTnT conce
and education (more than high school). ‡Comorbidities: bodymass ind
stroke, major electrocardiographic abnormality, and self-reported health.
cTnT  cardiac troponin T; other abbreviations as in Table 2.confirmed that greater self-reported physical activity,
whether measured by the weekly energy expenditure in
leisure activities or by walking pace, is inversely associated
with adverse cardiovascular endpoints including death (21).
owever, physical activity, unlike many traditional risk
actors, is a dynamic factor in older adults. Adaptation to a
ore physically active or sedentary lifestyle appears to be
ssociated with a change in cardiovascular risk over a period
f only 5 to 7 years (5–7). In sedentary older adults, exercise
raining over 1 year is associated with increased arterial
ompliance, physiological left ventricular remodeling, and
ncreased aerobic exercise capacity (22). These findings
uggest that physical activity may favorably modify the
ardiovascular and arterial substrate leading to HF over a
elatively short period of time.
We previously showed in this cohort that increases in
TnT or NT-proBNP levels over 2 to 3 years are associated
ith approximately a 60% and 200% higher long-term risk,
espectively, for the development of new-onset HF, inde-
endent of baseline levels, demographic variables, and
raditional cardiovascular risk factors (1,3). Using these
ame definitions for a significant increase in biomarkers, we
ound that the most physically active individuals in the CHS
th Clinically Significantaseline and Follow-up NT-proBNPity Score With Clinically Significant
ents With Baseline and Follow-up NT-proBNP
raphic Variable† Adjusted
(n  2,933)
Comorbidity‡ Adjusted
(n  2,873)
Reference Reference
0.79 (0.58–1.09) 0.75 (0.53–1.04)
0.56 (0.41–0.76) 0.56 (0.40–0.78)
0.52 (0.38–0.70) 0.53 (0.39–0.74)
0.60 (0.44–0.82) 0.60 (0.43–0.84)
0.46 (0.31–0.69) 0.50 (0.33–0.76)
p  0.001 p  0.001
% and a follow-up NT-proBNP of190 pg/ml. All models additionally
education. ‡Comorbidities: body mass index, diabetes, hypertension,
ographic abnormality, and self-reported health.
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tectable cTnT at Baseline (n  1,757)
raphic Variable† Adjusted
(n  1,757)
Comorbidity Adjusted‡
(n  1,718)
Reference Reference
0.73 (0.48–1.09) 0.69 (0.45–1.05)
0.70 (0.47–1.03) 0.72 (0.48–1.08)
0.65 (0.44–0.96) 0.69 (0.46–1.04)
0.49 (0.32–0.75) 0.52 (0.33–0.81)
0.27 (0.15–0.49) 0.30 (0.16–0.55)
p  0.001 p  0.001
e. Participants with a50% decrease were combined with those with
n. †Demographic variables: age, sex, race (African American or other),
etes, hypertension, coronary heart disease, claudication, emphysema,e Wiith BActiv
l Pati
emog
ne25
ce, ande WicTnActiv
th De
emog
baselin
ntratio
ex, diab
2545JACC Vol. 60, No. 24, 2012 deFilippi et al.
December 18, 2012:2539–47 Physical Activity and Biomarker Trajectorycohort were 70% and 50% less likely to have a significant
increase in cTnT and NT-proBNP, respectively, compared
with the most sedentary participants. The associations of
physical activity with biomarker increases were dose depen-
dent, with significant effects seen at even low levels of
activity and more robust effects at high levels. Similar
dose-dependent effects can be seen on outcomes starting
with low levels of physical activity (20). Potentially, the
absence of longitudinal increases in cTnT and NT-proBNP
could reflect the favorable effects of physical activity on
pathological left ventricular remodeling and arterial elas-
Figure 3 Rate of Incident HF
(A) Examined by baseline composite physical activity score and subsequent
increase in NT-proBNP. Error bars represent 95% confidence intervals. Tests for
trend across activity groups: p  0.02 for a significant increase in the
NT-proBNP group and p  0.001 for no significant increase in the NT-proBNP
group. (B) Examined by baseline composite activity score and subsequent
increase in cTnT. Error bars represent 95% confidence intervals. Tests for trend
across activity groups: p  0.002 for a significant increase in the cTnT group
and p  0.005 for no significant increase in the cTnT group. HF  heart fail-
ure; other abbreviations as in Figure 2.tance, resulting in less left ventricular wall stress and cardiacinjury. Higher levels of both NT-proBNP and cTnT are
associated with left ventricular hypertrophy and systolic
dysfunction in community-based cohort studies (23–25).
An increase in concentrations of these 2 cardiac biomarkers
likely reflects ongoing subclinical progression of cardiac
pathophysiology. In support of this concept, we recently
showed that participants with increasing NT-proBNP levels
were nearly twice as likely to progress from a normal to
abnormal (55%) left ventricular ejection fraction on
follow-up echocardiography compared with participants
without increasing levels (25).
Several additional mechanisms may contribute to the
inverse association between physical activity and increase in
markers of cellular injury and hemodynamic stress. For
example, telomere shortening occurs with aging and is
associated with cellular apoptosis and increased risk of
cardiovascular events (26–28). Habitual physical activity has
been shown to prevent myocyte, endothelial, and leukocyte
apoptosis via up-regulation of telomere-stabilizing proteins
and telomerase in both animal models and humans (26,27).
In another animal model of aging, long-term exercise was
associated with improved neo-revascularization of the myo-
cardium, with increased capillary density in response to
muscle ischemia and enhanced endothelial progenitor cell
homing to the ischemic territory (29). Such a mechanism
could result in mitigation of myocyte cell death after
pathological insult. Furthermore, in a mouse model of
mitochondrial DNA mutagenesis resulting in rapid aging,
long-term exercise induced systemic mitochondrial biogen-
esis and improved function, resulting in the prevention of
left ventricular hypertrophy compared with sedentary mice
(30). Increasing levels of NT-proBNP and hs cTnT may
reflect preclinical pathological precursors of hemodynamic
stress and injury that are prevented with physical activity.
Despite a large volume of epidemiological evidence and
guidelines recommending at least moderate physical activity
5 days a week, only 3.8% of Americans achieve this
recommendation (31). Given the long latency period be-
tween the onset of HF risk factors and the development of
symptoms, it can be challenging to motivate patients to
adopt or maintain lifestyles in which there is no near-term
clinical outcome or objective surrogate evidence of success-
ful implementation of a preventive strategy (32). The
findings of our study raise the possibility that hs markers of
myocardial injury and cardiac stretch/dysfunction could be
used to evaluate the efficacy and adherence to a prescription
of moderate to more intense physical activity by following
serial levels of these biomarkers over time. However, such a
strategy would need to be evaluated prospectively in a
controlled trial.
We did not find that those participants in the highest
physical activity category were more likely to have a signif-
icant longitudinal reduction in either cTnT or NT-
proBNP. Several factors may have contributed to our
inability to demonstrate a reduction in biomarker levels with
higher activity. It is possible that although physical activity,
2546 deFilippi et al. JACC Vol. 60, No. 24, 2012
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prevent further injury, it cannot reverse the process. Also,
the statistical power for detecting associations with decreas-
ing biomarker levels was modest due to the smaller number
of participants who have a decrease compared with an
increase in their cTnT level. Our findings are in contrast to
the beneficial effects of physical exercise that have been
documented to lead to a marked decrease in NT-proBNP
and hs cTnT levels after acute myocardial infarction or
cardiac surgery hospitalization, respectively (33,34). How-
ever, in these patients, the baseline biomarkers were gener-
ally 9- to 10-fold higher at baseline than in our community-
dwelling subjects and represent a more acute change in
pathophysiology likely involving favorable left ventricular
remodeling. Last, acute increases in both hs cTnT and
NT-proBNP can be seen immediately after strenuous exer-
cise such as a marathon race, but typically return to baseline
within 72 h (35). Of course, the intensity of the estimated
physical activity in the older CHS participants is much less
rigorous. Therefore, the biomarker levels measured at the
study visits are unlikely to be influenced by the amount of
mild to moderate exercise within the previous days.
Study limitations. There are several limitations that need
to be considered when interpreting the results of this study.
Leisure-time physical activity and walking pace were mea-
sured by self-reported questionnaires. Although these self-
reported measures and their combination have been strongly
associated with multiple long-term cardiovascular and non-
cardiovascular outcomes within the CHS and in other
cohort studies (10,11,18,21), they lack the objectivity of
direct measurement of activity levels. Therefore, misclassi-
fication of physical activity may be present, which could
have biased the association with an increase in cardiac-
specific biomarkers toward the null. However, the finding
that self-reported physical activity was inversely associated
with incident HF over a median of 10 years suggests that, as
in other large cohort studies, this method of assessment is
valid (21). Furthermore, despite adjustment for multiple
comorbidities associated with the risk of HF and impeding
regular exercise, physical activity may simply be a marker
rather than a mediator of cardiac health in this cohort.
However, the finding of a similar association in individuals
free of major comorbidities and after excluding participants
who perceived their health as fair or poor suggests that the
relationship between physical activity level and biomarker
evidence of progressive cardiac pathophysiology may be
causal.
Conclusions
The proportion of older adults who experienced an increase
in concentrations of cardiac-specific biomarkers of injury
and hemodynamic stress are inversely associated with self-
reported levels of physical activity in this cohort of
community-dwelling adults free of HF. Physical activity was
also inversely associated with the risk of the development ofHF. Serial monitoring of these biomarkers may provide an
early window into the pathophysiology associated with
sedentary lifestyle and the risk of HF. Our findings raise the
possibility that the trajectory of biomarker change and the
subsequent HF risks associated with increasing levels may
be modifiable by changes in lifestyle even at an advanced
age.
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